Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

ClearPoint Neuro, Inc. (CLPT) had Revenue of $9.21M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$9.21M
Net Income	$-5.84M
Cost of Goods Sold	$3.66M
Gross Profit	$5.56M
Operating Expenses	$14.89M
Operating Income	$-5.68M
Non-Operating Income/Expense	$-0.13M
Pre-Tax Income	$-5.81M
Normalized Pre-Tax Income	$-5.81M
Income after Taxes	$-5.84M
Income from Continuous Operations	$-5.84M
Consolidated Net Income/Loss	$-5.84M
Normalized Income after Taxes	$-5.84M
EBIT	$-5.68M
EBITDA	$-5.03M
Weighted-Average Shares Outstanding (Basic)	28.26M
Weighted-Average Shares Outstanding (Diluted)	28.26M
Earnings per Share (EPS) (Basic)	$-0.21
Earnings per Share (EPS) (Diluted)	$-0.21
Balance Sheet Financials
Current Assets	$53.99M
Property, Plant, and Equipment	$2.02M
Long-Term Assets	$8.88M
Total Assets	$62.87M
Current Liabilities	$7.40M
Long-Term Debt	$28.84M
Long-Term Liabilities	$35.73M
Total Liabilities	$43.13M
Common Equity	$19.74M
Tangible Shareholders Equity	$19.74M
Shareholders Equity	$19.74M
Common Shares Outstanding	28.42M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-8.72M
Cash Flow from Investing Activities	$-0.27M
Cash Flow from Financial Activities	$30.61M
Beginning Cash	$20.10M
End Cash	$41.72M
Increase/Decrease in Cash	$21.62M
Stock-Based Compensation	$4.18M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	7.30
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.59
Debt to Equity Ratio	1.46
Gross Margin	60.29%
Operating Margin	-61.64%
EBIT Margin	-61.64%
EBITDA Margin	--
Pre-Tax Profit Margin	-63.07%
Profit Margin	-63.34%
Free Cash Flow	$-9.00M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.15
Inventory Turnover	0.58
Receiveable Turnover	2.16
Days Sales in Receivables	41.61
Return on Equity	-29.56%
Return on Tangible Equity	-29.56%
Return on Assets	-9.28%
Return on Investments	-12.01%
Book Value Per Share	$0.69
Free Cash Flow per Share	$-0.32
Operating Cash Flow per Share	$-0.31

Data from Zacks Investment Research, Inc.